umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The use of Respiratory Syncytial Virus immunoprophylaxis Palivizumab in Children with Congenital Heart Disease in Sweden
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics.
2012 (English)Independent thesis Advanced level (professional degree), 20 credits / 30 HE creditsStudent thesis
Place, publisher, year, edition, pages
2012.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:umu:diva-81294OAI: oai:DiVA.org:umu-81294DiVA: diva2:653863
External cooperation
Västerbottens Läns Landsting. Pediatrik
Educational program
Medical Programme
Supervisors
Examiners
Available from: 2013-10-09 Created: 2013-10-06 Last updated: 2015-04-07Bibliographically approved

Open Access in DiVA

omslag(31 kB)7 downloads
File information
File name COVER01.pdfFile size 31 kBChecksum SHA-512
dc2b28fcaa6048853feec466880ce85c8d35d760683c5866a56004f751855e0b9e86270fcdf092a688299386a29a136d23680740a9e4710a40001ca88d0fe3fc
Type coverMimetype application/pdf

By organisation
Paediatrics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 38 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf